𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Low-dose cytosine arabinoside as remission induction therapy in refractory adult acute lymphocytic leukemia

✍ Scribed by Pall T. Onundarson; Jacob M. Rowe

Book ID
115682772
Publisher
Elsevier Science
Year
1989
Tongue
English
Weight
338 KB
Volume
86
Category
Article
ISSN
1555-7162

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Idarubicin and standard-dose cytosine ar
Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemia
✍ Merat Karbasian-Esfahani; Peter H. Wiernik; Yelena Novik; Elisabeth Paietta; Jan πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 79 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Drug resistance and early disease recurrence were major contributing factors in the limited survival of patients with acute lymphocytic leukemia (ALL). New chemotherapeutic agents and drug combinations were employed in refractory patients to overcome drug resistance. ##

High-dose methotrexate for the remission
High-dose methotrexate for the remission induction of refractory adult acute lymphocytic leukemia
✍ Peterson, Bruce A. ;Bloomfield, Clara D. πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 English βš– 357 KB

Six adults with refractory acute lymphocytic leukemia (ALL) were treated with high-dose methotrexate, citrovorum factor, and vincristine. All patients had previously received extensive treatment with standard therapeutic agents, including vincristine, and all but one had received prior methotrexate.